Izun Pharmaceuticals Corporation, a clinical stage company focused on developing high efficacy products based on compounds derived from botanical sources, has appointed Jack Talley as its chief executive officer. Mr. Talley brings over 30 years of relevant experience in the pharmaceutical industry, 15 of which were as chief executive in emerging pharmaceutical companies. Most recently, Mr. Talley was chief executive and president of Alissa Pharma, a company focusing on radioimmunotherapy util...